SPARCL1 and Alzheimer disease: When investigating this phenomenon using in vivo models of cognitive decline, we found that Hevin levels were decreased in hippocampal astrocytes when compared to WT animals, which was also observed in human astrocytes of AD patients compared to non‐demented elderly, as indicated by single cell RNAseq studies (Figure 1).